Search details
1.
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis.
Nature
; 574(7777): 273-277, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31578525
2.
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.
Blood
; 130(6): 732-741, 2017 08 10.
Article
in English
| MEDLINE | ID: mdl-28588019
3.
Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells.
Haematologica
; 102(11): 1850-1860, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28912174
4.
Familial hematological malignancies: new IDH2 mutation.
Ann Hematol
; 95(12): 1943-1947, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27591990
5.
A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model.
J Inherit Metab Dis
; 39(6): 807-820, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27469509
6.
Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation.
Nat Med
; 29(6): 1358-1363, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37248298
7.
The transcription factor Srf regulates hematopoietic stem cell adhesion.
Blood
; 116(22): 4464-73, 2010 Nov 25.
Article
in English
| MEDLINE | ID: mdl-20709909
8.
NUP98-MLL fusion in human acute myeloblastic leukemia.
Blood
; 116(13): 2332-5, 2010 Sep 30.
Article
in English
| MEDLINE | ID: mdl-20558618
9.
Functional analysis of the NUP98-CCDC28A fusion protein.
Haematologica
; 97(3): 379-87, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22058212
10.
Activating mutations in human acute megakaryoblastic leukemia.
Blood
; 112(10): 4220-6, 2008 Nov 15.
Article
in English
| MEDLINE | ID: mdl-18755984
11.
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.
Nat Med
; 24(8): 1167-1177, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30013198
12.
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.
ACS Med Chem Lett
; 9(4): 300-305, 2018 Apr 12.
Article
in English
| MEDLINE | ID: mdl-29670690
13.
Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.
Cancer Res
; 65(8): 3281-9, 2005 Apr 15.
Article
in English
| MEDLINE | ID: mdl-15833861
14.
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.
Cancer Discov
; 7(5): 478-493, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28193778
15.
IDH1, Histone Methylation, and So Forth.
Cancer Cell
; 30(2): 192-194, 2016 08 08.
Article
in English
| MEDLINE | ID: mdl-27505668
16.
Quantitation of isocitrate dehydrogenase (IDH)-induced D and L enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applications.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1022: 290-297, 2016 Jun 01.
Article
in English
| MEDLINE | ID: mdl-27131892
17.
Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.
Oncotarget
; 6(28): 24969-77, 2015 Sep 22.
Article
in English
| MEDLINE | ID: mdl-26327213
18.
Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.
J Clin Oncol
; 32(4): 297-305, 2014 Feb 01.
Article
in English
| MEDLINE | ID: mdl-24344214
19.
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations.
Leukemia
; 32(9): 2008-2081, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29479068
20.
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation.
Science
; 340(6132): 622-6, 2013 May 03.
Article
in English
| MEDLINE | ID: mdl-23558173